Los Altos, CA
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
altoneuroscience.comThese are collections Alto Neuroscience is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$49,999,533
Grant
$11,700,000
IPO
Unknown
Series Unknown
$59,261,815
Series C
$45,000,000
Series B
$25,000,000
Debt Financing
$35,000,000
Series B
$35,000,000
Series A
$32,000,000
Seed
$8,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Alto Neuroscience.